Posted:
1/31/2004
pls see see
YONKERS, N.Y., Jan. 8 /PRNewswire-FirstCall/ -- Advanced Viral Research Corp. (BULLETIN BOARD: ADVR) today announced that it has been awarded U.S. Patent Number 6.670,118 entitled "Method for Treating Papillomavirus Infections". The patent describes the use of AVR118 (previously known as Product R) for the topical treatment of patients suffering with lesions resulting from human papillomavirus (HPV) infections, including genital wartsComments:
|
|||